Tag Archives: interleukins
Inflammatory cytokines profile and oxidative stress markers in the serum of albino rats injected with macrophage migration inhibitory factor
N. T. Guliyeva1, S. V. Guliyeva2*, R. A. Akhundov2,
N. R. Jabbarova3, T. A. Eyvazov2
1Department of Cytology, Embryology and Histology,
Azerbaijan Medical University, Baku, Azerbaijan;
2Research Center, Azerbaijan Medical University, Baku, Azerbaijan;
3Department of Health Care Organization,
Azerbaijan Medical University, Baku, Azerbaijan;
*e-mail: quliyevasevda789@gmail.com
Received: 09 July 2025; Revised: 28 August 2025;
Accepted: 28 November 2025; Available on-line: 23 December 2025
Macrophage migration inhibitory factor (MIF) is a pleiotropic cytokine involved in the regulation of inflammation, immune responses, and redox homeostasis. However, its metabolic effects in experimental models remain insufficiently characterized. The aim of the work was to estimate the effect of recombinant MIF on cytokines profile, antioxidant defense markers and LPO indicators at different time points following its single intraperitoneal administration to albino rats. Animals were divided into a control group (n = 20) and three experimental groups (n = 10 each) assessed in 2, 3, and 14 days after MIF administration (10 µg/kg of b.w.), respectively. Serum samples were analyzed for IL-6, IL-10, TNF-α, IL-4, antioxidant markers and LPO products levels by ELISA and standard biochemical assays. It was shown that MIF administration induced time-dependent pro-inflammatory and pro-oxidant effects. Early compensatory anti-inflammatory responses were marked by increased IL-10 and decreased IL-6 levels. However, at the later stages (days 3 and 14), IL-6 and TNF-α elevation, along with IL-4 suppression, indicated a shift toward chronic inflammation. Antioxidant parameters progressively declined, with maximal suppression observed on day 14. Concurrently, a significant accumulation of LPO products confirmed sustained oxidative stress and membrane damage. These findings underscore the potential of MIF as a pharmacological target for the treatment of chronic inflammatory and metabolic disorders.
Antioxidant status and glutathione redox potential of erythrocytes in patients with acute coronary syndrome
I. V. Buko1, L. Z. Polonetsky1, A. G. Mrochek1, A. G. Moiseenok2
1Republican Scientific-Practical Center Cardiology, Minsk;
e-mail: buko_iv@rambler.ru;
2Scientific-Practical Center for Foodstuffs,
National Academy of Sciences of Belarus, Minsk
Indicators of oxidative stress (OS), systemic inflammation, metabolism and redox status of glutathione (GSH) were investigated and compared in patients with ST-segment elevation myocardial infarction on electrocardiograms (STEMI), and patients with unstable angina (UA). The elevated and decreased myeloperoxidase level, superoxide dismutase activity, and moderate increased plasma levels of interleukin-6, while maintaining the antioxidant potential, were found in Group 1. Disorders in pro-/antioxidant balance and systemic inflammatory response were manifested in UA. Increased GSH concentration (and total GSH) in erythrocytes has been established for STEMI patients and the decreased GSH for UA patients. Thus, a significant shift of erythrocytes redox to oxidization and increase (unlike STEMI patients) of glutathione peroxidase activity were recorded. Mechanisms of the pro- and antioxidant functions of red blood cells in acute coronary syndrome are considered. The role of red blood cell glutathione to provide more oxidized intravascular environment for S-glutathionylation and optimization of redox signaling in target cells is pronounced.